Cargando…
A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis
BACKGROUND: Benvitimod cream, a novel synthetic small molecule, was effective in treating mild-to-moderate plaque psoriasis. We conducted a phase III clinical trial to assess the efficacy and safety of benvitimod cream in patients with mild-to-moderate plaque psoriasis. METHODS: We randomly assigned...
Autores principales: | Cai, Lin, Chen, Gen-Hui, Lu, Qian-Jin, Zheng, Min, Li, Yu-Zhen, Chen, Jin, Zheng, Jie, Zhang, Fu-Ren, Yu, Jian-Bin, Yang, Sen, Li, Fu-Qiu, Xiao, Sheng-Xiang, Sun, Qiu-Ning, Xu, Jin-Hua, Gao, Xing-Hua, Fang, Hong, Gao, Tian-Wen, Hao, Fei, Liu, Quan-Zhong, Tu, Ya-Ting, Li, Ruo-Yu, Wang, Bao-Xi, Deng, Dan-Qi, Zheng, Qing-Shan, Liu, Hong-Xia, Zhang, Jian-Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752683/ https://www.ncbi.nlm.nih.gov/pubmed/33177393 http://dx.doi.org/10.1097/CM9.0000000000001221 |
Ejemplares similares
-
A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis
por: Cai, Lin, et al.
Publicado: (2023) -
Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream
por: Spencer, Riley K, et al.
Publicado: (2023) -
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis
por: Cai, Lin, et al.
Publicado: (2020) -
Pharmacokinetics and Safety of Icotinib Hydrochloride Cream in Patients with Mild to Moderate Chronic Plaque Psoriasis: A Randomized Double-Blind Vehicle-Controlled Phase 1 Study
por: Liu, Lunfei, et al.
Publicado: (2019) -
Integrated bioinformatic analysis of differentially expressed genes and signaling pathways in plaque psoriasis
por: Zhang, Yu-Jing, et al.
Publicado: (2019)